Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

The multiplicity of actions of benzodiazepine receptor ligands.

Haefely WE, Martin JR, Richards JG, Schoch P.

Can J Psychiatry. 1993 Nov;38 Suppl 4:S102-8. Review.

PMID:
8306240
2.

Environmental stimulation promotes changes in the distribution of phorbol ester receptors.

Spieler K, Schoch P, Martin JR, Haefely W.

Pharmacol Biochem Behav. 1993 Nov;46(3):553-60.

PMID:
8278432
3.

Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs.

Jenck F, Moreau JL, Mutel V, Martin JR, Haefely WE.

Eur J Pharmacol. 1993 Feb 9;231(2):223-9.

PMID:
8453978
4.

Effects of moclobemide, a new generation reversible Mao-A inhibitor, in a novel animal model of depression.

Moreau JL, Jenck F, Martin JR, Mortas P, Haefely W.

Pharmacopsychiatry. 1993 Jan;26(1):30-3.

PMID:
8378409
5.

Pharmacology of moclobemide.

Haefely W, Burkard WP, Cesura A, Colzi A, Kettler R, Lorez HP, Martin JR, Moreau JL, Richards JG, Schaffner R, et al.

Clin Neuropharmacol. 1993;16 Suppl 2:S8-18. Review.

PMID:
8313402
6.

Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence.

Schoch P, Moreau JL, Martin JR, Haefely WE.

Biochem Soc Symp. 1993;59:121-34. Review.

PMID:
7910739
7.

Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero.

Martin JR, Schoch P, Jenck F, Moreau JL, Haefely WE.

Psychopharmacology (Berl). 1993;111(4):415-22.

PMID:
7870982
8.

Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats.

Moreau JL, Jenck F, Martin JR, Perrin S, Haefely WE.

Psychopharmacology (Berl). 1993;110(1-2):140-4.

PMID:
7870874
9.

Behavioral profile of the 5HT1A receptor antagonist (S)-UH-301 in rodents and monkeys.

Moreau JL, Griebel G, Jenck F, Martin JR, Widmer U, Haefely WE.

Brain Res Bull. 1992 Dec;29(6):901-4.

PMID:
1473022
10.

Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.

Jenck F, Moreau JL, Bonetti EP, Martin JR, Haefely WE.

J Pharmacol Exp Ther. 1992 Sep;262(3):1121-7.

PMID:
1356150
11.

Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.

Facklam M, Schoch P, Bonetti EP, Jenck F, Martin JR, Moreau JL, Haefely WE.

J Pharmacol Exp Ther. 1992 Jun;261(3):1113-21.

PMID:
1318371
13.
14.

Aniracetam improves radial maze performance in rats.

Martin JR, Cumin R, Aschwanden W, Moreau JL, Jenck F, Haefely WE.

Neuroreport. 1992 Jan;3(1):81-3.

PMID:
1611039
15.

Biochemistry and pharmacology of moclobemide, a prototype RIMA.

Haefely W, Burkard WP, Cesura AM, Kettler R, Lorez HP, Martin JR, Richards JG, Scherschlicht R, Da Prada M.

Psychopharmacology (Berl). 1992;106 Suppl:S6-14. Review.

PMID:
1546143
16.

Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders.

Haefely W, Facklam M, Schoch P, Martin JR, Bonetti EP, Moreau JL, Jenck F, Richards JG.

Adv Biochem Psychopharmacol. 1992;47:379-94. Review.

PMID:
1324584
17.

Psychopharmacology of anxiety.

Haefely W.

Eur Neuropsychopharmacol. 1991 May;1(2):89-95. Review.

PMID:
1687977
18.

Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028.

Moreau JL, Jenck F, Pieri L, Schoch P, Martin JR, Haefely WE.

Eur J Pharmacol. 1990 Nov 6;190(1-2):269-73.

PMID:
1981753
19.

Novel anxiolytics that act as partial agonists at benzodiazepine receptors.

Haefely W, Martin JR, Schoch P.

Trends Pharmacol Sci. 1990 Nov;11(11):452-6. Review.

PMID:
1980040
20.

The GABA-benzodiazepine interaction fifteen years later.

Haefely W.

Neurochem Res. 1990 Feb;15(2):169-74. Review.

PMID:
2159122
21.

Some basic aspects of reversible inhibitors of monoamine oxidase-A.

Da Prada M, Kettler R, Burkard WP, Lorez HP, Haefely W.

Acta Psychiatr Scand Suppl. 1990;360:7-12.

PMID:
2248079
22.

Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humans.

Haefely WE, Kettler R, Keller HH, Da Prada M.

Adv Neurol. 1990;53:505-12. No abstract available.

PMID:
2122653
23.

Pre-clinical pharmacology of moclobemide. A review of published studies.

Burkard WP, Da Prada M, Keller HH, Kettler R, Haefely W.

Br J Psychiatry Suppl. 1989 Oct;(6):84-8. Review.

PMID:
2695131
24.

Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

Da Prada M, Kettler R, Keller HH, Burkard WP, Muggli-Maniglio D, Haefely WE.

J Pharmacol Exp Ther. 1989 Jan;248(1):400-14.

PMID:
2783611
25.

Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.

Da Prada M, Kettler R, Keller HH, Burkard WP, Haefely WE.

J Neural Transm Suppl. 1989;28:5-20. Review.

PMID:
2677242
26.

Pharmacology of the benzodiazepine receptor.

Haefely WE.

Eur Arch Psychiatry Neurol Sci. 1989;238(5-6):294-301. Review.

PMID:
2569974
27.

The story and activity of flumazenil (Anexate).

Haefely WE.

Acta Anaesthesiol Belg. 1989;40(1):3-9. No abstract available.

PMID:
2471385
28.

Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor.

Martin JR, Pieri L, Bonetti EP, Schaffner R, Burkard WP, Cumin R, Haefely WE.

Pharmacopsychiatry. 1988 Nov;21(6):360-2. No abstract available.

PMID:
2907644
29.

Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices.

Pizzi M, Da Prada M, Valerio A, Memo M, Spano PF, Haefely WE.

Brain Res. 1988 Jul 26;456(2):235-40.

PMID:
2974746
30.

On tyramine, food, beverages and the reversible MAO inhibitor moclobemide.

Da Prada M, Zürcher G, Wüthrich I, Haefely WE.

J Neural Transm Suppl. 1988;26:31-56. Review.

PMID:
3283290
31.

The story of flumazenil.

Haefely W, Hunkeler W.

Eur J Anaesthesiol Suppl. 1988;2:3-13. Review.

PMID:
2842141
32.

The preclinical pharmacology of flumazenil.

Haefely W.

Eur J Anaesthesiol Suppl. 1988;2:25-36. Review.

PMID:
2842136
33.

Endogenous ligands of the benzodiazepine receptor.

Haefely W.

Pharmacopsychiatry. 1988 Jan;21(1):43-6.

PMID:
2834760
34.

Benzodiazepines.

Haefely WE.

Int Anesthesiol Clin. 1988 Winter;26(4):262-72. Review.

PMID:
2461909
35.
36.

Dopamine D2 receptor stimulation decreases the inositol trisphosphate level of rat striatal slices.

Pizzi M, D'Agostini F, Da Prada M, Spano PF, Haefely WE.

Eur J Pharmacol. 1987 Apr 14;136(2):263-4. No abstract available.

PMID:
2954833
38.
39.

L-cycloserine: behavioural and biochemical effects after single and repeated administration to mice, rats and cats.

Polc P, Pieri L, Bonetti EP, Scherschlicht R, Moehler H, Kettler R, Burkard W, Haefely W.

Neuropharmacology. 1986 Apr;25(4):411-8.

PMID:
3012401
40.

Benzodiazepine receptors resolved.

Richards JG, Schoch P, Möhler H, Haefely W.

Experientia. 1986 Feb 15;42(2):121-6. Review.

PMID:
3005023
41.
42.

Co-localization of GABA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies.

Schoch P, Richards JG, Häring P, Takacs B, Stähli C, Staehelin T, Haefely W, Möhler H.

Nature. 1985 Mar 14-20;314(6007):168-71.

PMID:
2983231
44.

Biochemistry of anxiety.

Haefely W.

Ann Acad Med Singapore. 1985 Jan;14(1):81-3.

PMID:
2988406
45.

Pharmacology of benzodiazepine antagonists.

Haefely W.

Pharmacopsychiatry. 1985 Jan;18(1):163-6. No abstract available.

PMID:
2859619
46.

The pharmacology of Parkinson's disease: basic aspects and recent advances.

Da Prada M, Keller HH, Pieri L, Kettler R, Haefely WE.

Experientia. 1984 Nov 15;40(11):1165-72. Review.

PMID:
6437857
47.

Benzodiazepine interactions with GABA receptors.

Haefely W.

Neurosci Lett. 1984 Jun 29;47(3):201-6.

PMID:
6147796
48.

Some pharmacological effects of delta-sleep-inducing peptide (DSIP).

Scherschlicht R, Aeppli L, Polc P, Haefely W.

Eur Neurol. 1984;23(5):346-52.

PMID:
6548967
50.

Neurochemical effects in vitro and in vivo of the antidepressant Ro 11-1163, a specific and short-acting MAO-A inhibitor.

Da Prada M, Kettler R, Keller HH, Haefely WE.

Mod Probl Pharmacopsychiatry. 1983;19:231-45. No abstract available.

PMID:
6865966

Supplemental Content

Loading ...
Support Center